Intended for EU healthcare professionals only. The information on this website is not country-specific. This is an international disease awareness campaign.
Back
Video

In conversation with Assoc. Prof. Philipp Sewerin: Why should we aim for MDA? 

Treatment for PsA should target a broad range of musculoskeletal and extra-articular manifestations.1 Listen to Assoc. Prof. Philipp Sewerin explain how MDA can support your clinical treatment strategy:

Published on

16 Nov 2023

Get similar content directly to your inbox.

Never miss an insight. Register your interest and we'll let you know when new articles are published on this topic

BSA: body surface area; DAPSA: Disease Activity Index for PSoriatic Arthritis; MDA: minimal disease activity; PASI: Psoriasis Area and Severity Index; PsA: psoriatic arthritis.

1. Smolen JS et al. Ann Rheum Dis. 2018;77:3–17. 2. Smolen JS et al. Clin Exp Rheumatol. 2015;33:S48–50. 3. Coates LC et al. J Rheumatol. 2019;46(1):38–42